Keros Therapeutics, Inc.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

financial.report

Occurred

2026-03-31

Reported

2026-05-14

Disclosure lag

44 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	Keros Therapeutics, Inc.
Source	SEC EDGAR ↗
Source identifier	companyfacts/CIK0001664710/2026-07-26
Event ID	#29263

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001664710-26-000030",
  "canonical_covered": 11,
  "canonical_total": 12,
  "fiscal_period": "Q1",
  "fiscal_year": 2026,
  "form": "10-Q",
  "mapped_tag_share": 0.053497942386831275,
  "metrics": {
    "cash_and_equivalents": 281497000,
    "earnings_per_share_basic": -1.21,
    "earnings_per_share_diluted": -1.21,
    "net_income": -23708000,
    "operating_cash_flow": -3529000,
    "operating_income": -25877000,
    "revenue": 32000,
    "shareholders_equity": 285630000,
    "shares_outstanding": 19732837,
    "total_assets": 312293000,
    "total_liabilities": 26663000
  },
  "metrics_reported": 11,
  "period_end": "2026-03-31"
}

Source: SEC EDGAR · as of 2026-05-14T00:00:00Z